To investigate the biological function of P4HA2 in CRC progression, we conducted a CCK8 assay and revealed a significant difference in P4HA2 knockdown or over-expression between the control groups (Figure 4D). This evidence concerns the gene P4HA2 and colorectal carcinoma.